Soluble IFNAR2 in Parkinson's disease and its role in the regulation of IFNβ in a neuroinflammatory context.

Project Information

ParkIFNAR

Grant agreement ID: 893859

DOI 10.3030/893859

Closed project

EC signature date 27 February 2020

Start date 14 September 2020

End date 13 September 2022

Funded under

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Total cost € 207 312,00

EU contribution € 207 312,00

Coordinated by

KOBENHAVNS UNIVERSITET
Denmark